Sumitomo Mitsui Trust Group
TECH icon

Sumitomo Mitsui Trust Group’s Bio-Techne TECH Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146M Buy
2,067,324
+13,030
+0.6% +$704K 0.08% 229
2026
Q1 		$107M Sell
2,054,294
-313,868
-13% -$18.8M 0.07% 259
2025
Q4 		$139M Buy
2,368,162
+12,544
+0.5% +$762K 0.08% 220
2025
Q3 		$131M Buy
2,355,618
+5,906
+0.3% +$316K 0.08% 244
2025
Q2 		$121M Buy
2,349,712
+319,177
+16% +$16M 0.08% 245
2025
Q1 		$119M Sell
2,030,535
-10,305
-0.5% -$698K 0.08% 234
2024
Q4 		$147M Buy
2,040,840
+354,478
+21% +$26M 0.1% 197
2024
Q3 		$135M Sell
1,686,362
-28,632
-2% -$2.15M 0.09% 210
2024
Q2 		$123M Buy
1,714,994
+290,510
+20% +$21.4M 0.09% 211
2024
Q1 		$100M Sell
1,424,484
-16,710
-1% -$1.2M 0.07% 297
2023
Q4 		$111M Buy
1,441,194
+19,023
+1% +$1.25M 0.08% 255
2023
Q3 		$96.8M Buy
1,422,171
+57,129
+4% +$4.51M 0.08% 268
2023
Q2 		$111M Buy
1,365,042
+171,963
+14% +$13.8M 0.09% 244
2023
Q1 		$88.5M Buy
1,193,079
+178,504
+18% +$13.8M 0.07% 327
2022
Q4 		$84.1M Buy
1,014,575
+6,607
+0.7% +$525K 0.07% 338
2022
Q3 		$71.6M Buy
1,007,968
+18,852
+2% +$1.63M 0.06% 372
2022
Q2 		$85.7M Buy
989,116
+50,388
+5% +$4.72M 0.07% 334
2022
Q1 		$102M Sell
938,728
-100,056
-10% -$10.3M 0.07% 322
2021
Q4 		$134M Buy
1,038,784
+149,872
+17% +$18.4M 0.08% 262
2021
Q3 		$108M Sell
888,912
-50,872
-5% -$6.19M 0.07% 320
2021
Q2 		$106M Buy
939,784
+243,536
+35% +$25.6M 0.06% 342
2021
Q1 		$66.5M Sell
696,248
-47,988
-6% -$4.38M 0.04% 452
2020
Q4 		$59.1M Buy
744,236
+241,216
+48% +$17.5M 0.04% 471
2020
Q3 		$31.2M Sell
503,020
-336,384
-40% -$21.9M 0.02% 610
2020
Q2 		$55.4M Sell
839,404
-105,416
-11% -$6.31M 0.04% 464
2020
Q1 		$44.8M Sell
944,820
-6,296
-0.7% -$315K 0.04% 469
2019
Q4 		$52.2M Buy
+951,116
New +$49.9M 0.04% 466

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TECH Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Bio-Techne (TECH) stake by 0.63% in Q2 2026, buying an estimated $704K and bringing the position to 2,067,324 shares worth $146M. The position accounts for 0.08% of the portfolio, ranked #229.

Sumitomo Mitsui Trust Group first reported a position in TECH in Q4 2019 and has held it in 27 quarters since. The position peaked at $147M in Q4 2024. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 2,067,324 shares of Bio-Techne worth $146M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 13,030 Bio-Techne shares in Q2 2026, an estimated $704K.
  • Bio-Techne made up 0.08% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #229 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Bio-Techne in Q4 2019 and has held it in 27 quarters since.
  • Sumitomo Mitsui Trust Group's Bio-Techne position peaked at $147M in Q4 2024.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.